Apimeds Pharmaceuticals US (APUS) Prepaid Assets (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Prepaid Assets came in at $48500.0 in Q4 2025, up 405.1% YoY from $9602.0 in Q4 2024, and down 85.94% on a QoQ basis from $344990.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Prepaid Assets (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Prepaid Assets data on file, last reported at $48500.0 in Q4 2025.
- Quarterly Prepaid Assets rose 405.1% year-over-year to $48500.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $48500.0 (up 405.1% YoY) and the FY2025 annual result came in at $48500.0, up 405.1% from the prior year.
- Prepaid Assets retreated to $48500.0 in Q4 2025, from $344990.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.6 million in Q2 2025 to a low of $9562.0 in Q1 2025.
- A 3-year average of $339745.8 and a median of $30047.5 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets declined 17.19% — and 2025, when it soared 405.1%.
- Tracing APUS's Prepaid Assets over 3 years: stood at $11595.0 in 2023, then decreased by 17.19% to $9602.0 in 2024, then soared by 405.1% to $48500.0 in 2025.
- The last three Prepaid Assets figures came in at $48500.0 (Q4 2025), $344990.0 (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Apimeds Pharmaceuticals US | 7.68 Mn | 7.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48,500.00 |
| Sep 30, 2025 | 344,990.00 |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 9,562.00 |
| Dec 31, 2024 | 9,602.00 |
| Dec 31, 2023 | 11,595.00 |